HealthCor Catalio Acquisition Corp.

Status: Deal Closed
U=S
IPO Proceeds, $M $207.00M
IPO Date Jan 27, 2021
CEO Art Cohen
Left Lead Jefferies
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Healthcare, including the biotechnology, pharmaceuticals, services, and medical technology sub-sectors

IPO Geography Global
Target Company Hyperfine and Liminal Sciences
Deal Announced Jul 8, 2021
Deal Size, $M $581.30M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Dec 21, 2021
Amendment Vote TBD
Closing Date Dec 22, 2021
Formerly HCAQ HYPR

Sign up for Free Trial

No credit card required

Sign in for more on HealthCor Catalio Acquisition Corp.:

  • Structure and cap table
  • 9 directors & officers
  • 22 filings and events
  • 1 underwriters
  • 7 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Art Cohen 59 CEO and Director
Christine Clarke 42 CFO
George Petrocheilos 29 President
Joseph Healey 54 Chairman
Avi Horev 46 Director
Dr. Kenan Turnacioglu 50 Director
Michael Weinstein 50 Director
Taylor Harris 44 Director
Dr. Christopher Wolfgang 54 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Jefferies BR 18,000,000 units
18,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 22 filings.

Shareholders

Sign in to view shareholders 13F filing data.